v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities    
Net loss $ (48,618) $ (39,512)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 760 1,087
Stock-based compensation 6,738 6,646
Non-cash operating lease expense 467 395
Accretion of discount on marketable debt securities (433) (2,053)
Changes in operating assets and liabilities:    
Accounts receivable 0 (3,000)
Prepaid expenses and other current assets 1,510 (2,503)
Accounts payable (7,616) 4,553
Accrued expenses and other current liabilities 3,827 (4,673)
Operating lease liabilities (818) (700)
Other (23) (38)
Net cash used in operating activities (44,206) (39,798)
Investing activities    
Redemption of marketable debt securities 51,663 123,573
Purchase of marketable debt securities (13,993) (92,448)
Net cash provided by investing activities 37,670 31,125
Financing activities    
Proceeds received in advance of private placement 10,000 0
Proceeds from exercise of pre-funded warrants 0 2
Proceeds from the exercise of stock options 47 0
Tax withholding payments related to net settlement of restricted common stock and other awards (78) (69)
Net cash provided by (used in) financing activities 9,969 (67)
Net increase (decrease) in cash, cash equivalents and restricted cash 3,433 (8,740)
Cash, cash equivalents and restricted cash at beginning of year 16,894 20,945
Cash, cash equivalents and restricted cash at end of period 20,327 12,205
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 18,855 10,733
Restricted cash 1,472 1,472
Total cash, cash equivalents and restricted cash shown in the statement of cash flows $ 20,327 $ 12,205